Iomai Corporation
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD295—442m (Dealroom.co estimates Jan 2003.)
Gaithersburg Maryland (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$54.0m | Series C | ||
N/A | Acquisition | ||
| Total Funding | CAD73.6m | ||
Recent News about Iomai Corporation
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.